Epizyme (EPZM) Tops Q2 EPS by 3c

August 8, 2016 6:31 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Epizyme (NASDAQ: EPZM) reported Q2 EPS of ($0.49), $0.03 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $473 thousand versus the consensus estimate of $888 thousand.

For earnings history and earnings-related data on Epizyme (EPZM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment